АкушерствоАнатомияАнестезиологияВакцинопрофилактикаВалеологияВетеринарияГигиенаЗаболеванияИммунологияКардиологияНеврологияНефрологияОнкологияОториноларингологияОфтальмологияПаразитологияПедиатрияПервая помощьПсихиатрияПульмонологияРеанимацияРевматологияСтоматологияТерапияТоксикологияТравматологияУрологияФармакологияФармацевтикаФизиотерапияФтизиатрияХирургияЭндокринологияЭпидемиология

HIV activists protest over drug pricing policy

Прочитайте:
  1. Показатели липидного обмена (European Diabetes Policy Group, 1998 – 99).

by Alina Lobzina at 19/07/2012

The Moscow News

Russian HIV activists have accused pharmaceutical companies of cashing on vital medicines, focusing first on ViiV Healthcare, an HIV joint venture of GlaxoSmithKline and Pfizer.

Members of patient union Patsientsky Kontrol gathered on Thursday morning outside ViiV’s Moscow office to protest over its pricing policy, saying that in other countries the same treatment costs many times less.

“We don’t deny the companies right to gain superprofit from selling their products, but it’s essential to make it possible for people to survive,” said Sergei Golovin, one of the protest organizers.

Дата добавления: 2015-02-05 | Просмотры: 624 | Нарушение авторских прав


1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 | 21 | 22 | 23 | 24 | 25 | 26 | 27 | 28 | 29 | 30 | 31 | 32 | 33 | 34 | 35 | 36 | 37 | 38 | 39 | 40 | 41 | 42 | 43 | 44 | 45 | 46 | 47 | 48 | 49 | 50 | 51 | 52 | 53 | 54 | 55 | 56 | 57 | 58 | 59 | 60 | 61 | 62 | 63 | 64 | 65 | 66 | 67 | 68 | 69 | 70 | 71 | 72 | 73 | 74 | 75 | 76 | 77 | 78 | 79 | 80 | 81 | 82 | 83 | 84 | 85 | 86 | 87 |

При использовании материала ссылка на сайт medlec.org обязательна! (0.003 сек.)